Showing Results for: “diabetes exercise”

The American Diabetes Association® (ADA) announced today that the organization is encouraged by Pres. Biden’s FY’22 budget proposal for its prioritization of robust funding to support diabetes research, management, and care. “This budget request makes it clear that the administration acknowledges the risks posed by diabetes and other chronic conditions and the importance of supporting the millions of Americans with diabetes and prediabetes and their families,” said Tracey D. Brown, CEO of the ADA . “As the ADA continues its fight to prevent diabetes, improve the lives of those living with

In Texas, the ADA’s “friend of the court” brief urges clarification for Texas voters with diabetes and other chronic conditions On Monday, The American Diabetes Association® (ADA) filed an amicus curiae, or “friend of the court” brief in the federal court case Texas Democratic Party et al. v. Abbott et al. in the U.S. Court of Appeals for the Fifth Circuit, requesting clarification from the Court for voters with diabetes and other chronic diseases, so they may exercise their right to vote safely in this year’s elections. This brief is the second the ADA has filed in an effort to defend the

Multi-year public health campaign will raise awareness of the need for understanding and early detection of diabetes-related eye disease The American Diabetes Association (ADA) today announced Regeneron Pharmaceuticals, Inc., has joined VSP® Vision Care as a Visionary Partner to focus on an often overlooked but costly and devastating complication of diabetes: vision loss. This eye health initiative, “Focus on Diabetes,” will highlight the crucial role annual comprehensive eye exams play in the early detection, intervention and possible prevention of eye disease and vision loss caused by

Leading Diabetes Scientific Sessions Meeting Will Present Groundbreaking Data on Key Topics Including: Obesity, Technology, AI Health and the Latest in Diabetes Innovation From June 21–24, the American Diabetes Association® (ADA) will host the 84th Scientific Sessions in Orlando, FL. The ADA’s Scientific Sessions is the world’s largest diabetes meeting, convening more than 11,000 leading physicians, scientists, researchers and health care professionals from around the globe. The hybrid meeting will feature the latest scientific findings in diabetes, including more than 200 sessions and 2,000

The American Diabetes Association ® (ADA) and the European Association for the Study of Diabetes (EASD) announced today their new consensus update on management of hyperglycemia in type 2 diabetes. The update has been prepared by an international committee of experts that include John B. Buse, MD, PhD, (University of North Carolina School of Medicine, Chapel Hill, NC); Melanie J. Davies, CBE, MBChB, MD, FRCP, FRCGP, FMedSciat (Leicester Diabetes Centre, Leicester, UK); and their colleagues. It updates the previous 2018 and 2019 consensus reports, and like its predecessors, this new document